(USPH) US Physicalrapy - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90337L1089

USPH EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of USPH over the last 5 years for every Quarter.

USPH Revenue

This chart shows the Revenue of USPH over the last 5 years for every Quarter.

USPH: Physical Therapy, Injury Prevention

U.S. Physical Therapy, Inc. is a healthcare services provider that operates and manages a network of outpatient physical therapy clinics across the United States. The companys business model is diversified across two main segments: Physical Therapy Operations, which provides a range of physical therapy services to patients, and Industrial Injury Prevention Services, which offers specialized injury prevention and rehabilitation programs to corporate clients, including Fortune 500 companies.

The companys Physical Therapy Operations segment provides pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, and neurological-related injuries, as well as preventative care and rehabilitation services for injured workers. The Industrial Injury Prevention Services segment leverages physical therapists and certified athletic trainers to deliver onsite injury prevention and rehabilitation programs, performance optimization services, and ergonomic assessments to clients.

With a strong presence in the US healthcare market, U.S. Physical Therapy, Inc. has established a reputation for delivering high-quality physical therapy services. The companys business model is designed to capitalize on the growing demand for outpatient physical therapy services, driven by an aging population and an increasing focus on preventive care. As the company continues to expand its operations, it is well-positioned to benefit from trends in the US healthcare market.

Based on the current technical and fundamental data, a forecast for USPH can be made. The stock is currently trading at $77.34, with a 20-day SMA of $76.53, indicating a slight uptrend. The 50-day SMA is $73.01, and the 200-day SMA is $81.87, suggesting that the stock is experiencing a correction after a previous uptrend. The ATR of 2.44 (3.15%) indicates moderate volatility. Given the companys strong fundamentals, including a market cap of $1.17 billion and a forward P/E ratio of 31.85, we can expect the stock to appreciate in the coming months. A potential price target could be $85, representing a 10% increase from current levels.

To support this forecast, we can analyze the companys historical performance and industry trends. USPH has a history of delivering consistent revenue growth, driven by its expanding network of physical therapy clinics and increasing demand for its industrial injury prevention services. The healthcare industry is expected to continue growing, driven by an aging population and an increasing focus on preventive care. As a leading player in the outpatient physical therapy market, USPH is well-positioned to benefit from these trends, making it a potentially attractive investment opportunity.

Additional Sources for USPH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

USPH Stock Overview

Market Cap in USD 1,170m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 1992-05-28

USPH Stock Ratings

Growth Rating -19.7
Fundamental 16.9
Dividend Rating 65.5
Rel. Strength -12.7
Analysts 4.14 of 5
Fair Price Momentum 67.70 USD
Fair Price DCF 79.20 USD

USPH Dividends

Dividend Yield 12m 2.26%
Yield on Cost 5y 2.52%
Annual Growth 5y 40.63%
Payout Consistency 92.0%
Payout Ratio 73.9%

USPH Growth Ratios

Growth Correlation 3m 69.2%
Growth Correlation 12m -63.8%
Growth Correlation 5y -28.2%
CAGR 5y 1.04%
CAGR/Max DD 5y 0.02
Sharpe Ratio 12m -1.58
Alpha -27.14
Beta 0.804
Volatility 36.83%
Current Volume 213.1k
Average Volume 20d 162.8k
What is the price of USPH shares?
As of June 23, 2025, the stock is trading at USD 74.28 with a total of 213,122 shares traded.
Over the past week, the price has changed by -3.96%, over one month by -0.89%, over three months by +1.46% and over the past year by -20.32%.
Is US Physicalrapy a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, US Physicalrapy is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.85 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of USPH is around 67.70 USD . This means that USPH is currently overvalued and has a potential downside of -8.86%.
Is USPH a buy, sell or hold?
US Physicalrapy has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy USPH.
  • Strong Buy: 2
  • Buy: 4
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for USPH share price target?
According to our own proprietary Forecast Model, USPH US Physicalrapy will be worth about 74.7 in June 2026. The stock is currently trading at 74.28. This means that the stock has a potential upside of +0.54%.
Issuer Target Up/Down from current
Wallstreet Target Price 106 42.7%
Analysts Target Price 106 42.7%
ValueRay Target Price 74.7 0.5%